Thurston Springer Miller Herd & Titak’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.1K Sell
89
-803
-90% -$139K ﹤0.01% 822
2026
Q1
$177K Sell
892
-185
-17% -$43.1K 0.07% 278
2025
Q4
$289K Buy
+1,077
New +$274K 0.1% 196
2025
Q3
Sell
-18,154
Closed -$5.43M 545
2025
Q2
$5.43M Buy
18,154
+6,134
+51% +$1.87M 0.7% 23
2025
Q1
$3.75M Buy
12,020
+2,404
+25% +$849K 0.63% 35
2024
Q4
$3.38M Buy
9,616
+2,632
+38% +$947K 0.68% 24
2024
Q3
$2.47M Buy
6,984
+201
+3% +$66.1K 0.68% 22
2024
Q2
$2.06M Sell
6,783
-32,683
-83% -$10M 0.64% 23
2024
Q1
$13.7M Buy
+39,466
New +$14.4M 5.49% 4

Other funds holding ACN

Thurston Springer Miller Herd & Titak's ACN Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak reduced its Accenture (ACN) stake by 90% in Q2 2026, selling an estimated $139K and leaving 89 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #822.

Thurston Springer Miller Herd & Titak first reported a position in ACN in Q1 2024 and has held it in 9 quarters since. The position peaked at $13.7M in Q1 2024. 662 funds tracked by Wall St. Rank hold ACN as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 89 shares of Accenture worth $11.1K as of Q2 2026.
  • Thurston Springer Miller Herd & Titak sold 803 Accenture shares in Q2 2026, an estimated $139K.
  • Accenture made up ﹤0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #822 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in Accenture in Q1 2024 and has held it in 9 quarters since.
  • Thurston Springer Miller Herd & Titak's Accenture position peaked at $13.7M in Q1 2024.
  • 662 funds tracked by Wall St. Rank held Accenture as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.